InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Farag Kameel D.. Officer active across 1 company, notably Akari Therapeutics Plc. Cumulatively, 2 reports have been published. History available since 1 November 2025. The latest transaction was disclosed on 1 November 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
2 of 2 declarations